CBUS CIBUS INC

Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. Second Quarter 2025 Results Conference Call

Event Date: Thursday, August 14, 2025

Time: 4:30 p.m. ET

Participant Numbers: (U.S.), (International)

The conference ID “CIBUS” or 24287 will be required for entry

Event Link:

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, August 28, 2025, and can be accessed by dialing (U.S.), (International) and entering replay passcode: 11159575.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus’ long-term focus is productivity traits for farmers for the major global row crops. Cibus is not a seed company. It is a technology company that uses proprietary high-throughput gene editing technology to develop at a fraction of the time and cost of conventional breeding and to license them to seed companies in exchange for royalties on seed sales.

Cibus Contacts:

Investor Relations

Jeff Sonnek – ICR

Media Relations

Colin Sanford



203-918-4347



EN
05/08/2025

Underlying

CBUSCIBUS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus to Report Second Quarter 2025 Financial Results on August 14, 20...

Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report second quarter 2025 financial results on Thursday, August 14, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Q...

15h / 14m 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus Announces Steps to Implement More Streamlined Business Focus on ...

Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities Previously Announced Strategy Focus Prioritizes Opportunities in Rice and Biofragrance Products and Sustainable Ingredients with Initiatives Expected to Reduce Annual Net Cash Usage to Approximately $30M by 2026 Cibus Well Situated to Pursue Partner Funding to Support its Advanced Productivity Trait Portfolio SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops plant traits to license to s...

July 23, 2025 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

The U.S. Food and Drug Administration Completes Review of Cibus’ Alter...

The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed Completion of the U.S. Food and Drug Administration’s Plant Biotechnology Consultation Program enables U.S. commercialization of alfalfa with an altered lignin profile offering potential improved digestibility for livestock and greater harvest flexibility for farmers. SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant...

June 24, 2025 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus and John Innes Centre Announce Ongoing Collaboration with Potent...

Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming Researchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration with the potential to introduce the trait into several commercial crops Cibus previously announced the successful editing of Canola plants with this mutation and looks forward to further testing and trait validation SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -...

June 12, 2025 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus, Inc. Announces Closing of $27.5 Million Public Offering

Cibus, Inc. Announces Closing of $27.5 Million Public Offering SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the closing of its previously announced public offering of 15,714,285 shares of its Class A Common Stock, at a purchase price of $1.75 per share, including to institutional and strategic investors, as well as the Chairman of Cibus’ board of directors ...

June 10, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch